Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.
Clinical trial NCT03186378 · COMPLETED
Trial details
- NCT number
- NCT03186378
- Sponsor
- Verrica Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2018-06-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.